Myrexis, Inc.'s Net Worth

$308 Thousand

Estimate Recalculated Feb 7, 2024 04:01PM EST

Who is Myrexis, Inc.?

Myrexis, Inc. does not have any significant net worth to report based on the numbers we have. This is based on reported shares in ENZON PHARMACEUTICALS, INC..

SEC CIK

Myrexis, Inc.'s CIK is 0001459450

Past Insider Trading and Trends

2020 was Myrexis, Inc.'s most active year for acquiring shares with 5 total transactions. Myrexis, Inc.'s most active month to acquire stocks was the month of February. 2020 was Myrexis, Inc.'s most active year for disposing of shares, totalling 2 transactions. Myrexis, Inc.'s most active month to dispose stocks was the month of July. 2020 saw Myrexis, Inc. paying a total of $192,541.08 for 1,159,015 shares, this is the most they've acquired in one year. In 2021 Myrexis, Inc. cashed out on 107,500 shares for a total of $41,903.50, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

ENZON PHARMACEUTICALS, INC. (ENZN) Snapshot price: $0.09625

Investor

Myrexis, Inc. owns 4,616,482 units of Common Stock, $0.01 par value which is worth $444,336.39. In the year 2020 Myrexis, Inc. acquired a total of 1,159,015 shares in ENZON PHARMACEUTICALS, INC. at a cost of $192,541.08, Myrexis, also disposed a total of 184,600 shares of ENZON PHARMACEUTICALS, INC. equalling to $56,241.14.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-4.30%
-107.50K
$0.39
-$41,903.50
2.39M
Aug 13
Form 4
-4.62%
-77.10K
$0.19
-$14,337.64
1.59M
Aug 24 - Aug 25
Form 4
+31.76%
506.29K
$0.20
$101,258.40
2.1M
Aug 5
Form 3
—
0
—
—
0
Form 4/A
+41.45%
652.72K
$0.14
$91,282.68
2.23M
Mar 13 - Mar 26
Form 3
—
0
—
—
0
No matching records found